Pharmacokinetics of Fluoxetine in Rhesus Macaques following Multiple Routes of Administration
Authors:
Open Access
- 14 July 2011
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 88 (1-2) , 44-49
Abstract
Background/Aims: Fluoxetine (Prozac) is a selective serotonin reuptake inhibitor currently used to treat depression and mood disorders. It has been widely studied clinically and preclinically, yet there is limited knowledge of its pharmacokinetics in nonhuman primates. Methods: The present study characterized the pharmacokinetics of fluoxetine and its active metabolite norfluoxetine in rhesus macaques following both acute (1, 3, 5.6 and 10 mg/kg) and chronic doses (5.6 and 10 mg/kg/day) via different routes of administration (intravenous, subcutaneous, intramuscular, and oral). Blood samples were collected at multiple time points following administration and analyzed using mass spectrometry. Results: Fluoxetine had a half-life of 11–16 h and norfluoxetine had a half-life of 21–29 h. Potentially functionally significant serum concentrations of norfluoxetine were present at 24 h even after a single administration of fluoxetine. Similar to observations in humans under steady state conditions, norfluoxetine accounted for the greater percentage of active drug in the blood stream. Conclusion: A daily dose of 10 mg/kg administered orally maintained serum concentrations in the human clinical range over the course of 6 weeks. Given the long half-lives of fluoxetine and norfluoxetine observed in this study, precautions should be taken when designing preclinical studies to prevent accumulation of drug serum concentrations.Keywords
This publication has 17 references indexed in Scilit:
- Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortexPharmacology Biochemistry and Behavior, 2009
- Serum Concentrations of Antidepressant Drugs in a Naturalistic Setting: Compilation Based on a Large Therapeutic Drug Monitoring DatabaseTherapeutic Drug Monitoring, 2009
- Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatmentEuropean Neuropsychopharmacology, 2006
- The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in PsychiatryPharmacopsychiatry, 2004
- Onset of action of antidepressants: results of different analysesHuman Psychopharmacology: Clinical and Experimental, 2002
- Clinically Relevant Pharmacology of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1997
- Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???Clinical Pharmacokinetics, 1996
- Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publicationLife Sciences, 1995
- Clinical Pharmacokinetics of FluoxetineClinical Pharmacokinetics, 1994